Medent Quarterly User GroupKristin Cortese & Kendra Hennessey| 12.9.15

©2011 Proprietary and Confidential

Agenda

• Modified Stage 2 Changes• HCC Functionality in Medent• Care Plan Packages• Crimson Quality Reporting Overview

MODIFIED STAGE 2 UPDATES

©2011 Proprietary and Confidential

Removed Measures & Objectives

• Demographics• Vital signs• Smoking status• Clinical visit summaries• Structured lab results• Patient list• Patient reminders• Health Information Exchange(Summary of

Care)(measures 1 & 3)• Electronic progress notes• Images accessible through the EHR• Family history

©2011 Proprietary and Confidential

Retained Measures & Objectives

• CPOE• eRx & formulary check• Clinical decision support• Patient electronic access (measure 1)• Security risk analysis• Patient-specific education• Medication reconciliation• Health Information Exchange(Summary of Care)(measure

2)Reporting of Clinical Quality Measures (CQMs) is still required

©2011 Proprietary and Confidential

Changed Measures & Objectives

• Patient electronic access, view/download/ transmit (VDT) (measure 2)

• Secure electronic messaging• Specialized registry

©2011 Proprietary and Confidential

Patient Electronic Access (VDT)

At least 1 patient seen by the EP during the reporting period views, downloads or transmits his/her health information to a third party• Changed from 5% to only 1 patient

©2011 Proprietary and Confidential

Secure Electronic Messaging

During the EHR reporting period, the capability for patients to send and receive a secure electronic message with the provider was fully enabled• Changed from 5% to capability enabled

©2011 Proprietary and Confidential

Public Health & Clinical Data Reporting

Measure The EP is in active engagement to submit:

1 – Immunization Registry Reporting

Immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS)

2 – Syndromic Surveillance Reporting

Syndromic surveillance data from a non-urgent care ambulatory setting.

3 – Specialized Registry Reporting

Data to a specialized registry

EPs in Stage 2 must attest to 2 of the 3 measuresEPs in Stage 1 must attest to 1 of the 3 measures

©2011 Proprietary and Confidential

Summary of Modified Stage 2Measure Stage 1, 2015 only Stage 2 in 2015 & beyondCPOE MedicationsCPOE LaboratoryCPOE Radiology

>30%ExclusionExclusion

>60%>30%>30%

eRx and formulary checks >40%, formulary check not required

>50%

Clinical Decision Support 1 CDS rule 5 CDS rules related to 4 or more CQM’s & drug-drug, drug-allergy checks

Patient Electronic AccessView, Download, Transmit (VDT)

>50% have accessExclusion

>50% have accessAt least 1 patient

Security Risk Analysis Complete CompletePatient-specific education Exclusion >10%Medication Reconciliation Exclusion >50%Health Information Exchange Exclusion >10% sent electronicallySecure Electronic Messaging Exclusion Capability fully enabledPublic/Population Health Report on 1 Report on 2

HCC FUNCTIONALITY IN MEDENT

©2011 Proprietary and Confidential

New HCC Feature

• Ability to enable highlighting of dx codes that are assigned to HCC’s

• Allows user to easily identify HCC codes in a patients dx list that have not been assessed in the CURRENT year.

• Feature needs to be turned on PER user, done through the DX Selection setup screen

• http://medent.com/tutorials_mp4/hcc-highlighting.mp4

CARE PLAN PACKAGESPRESENTER: KENDRA

HENNESSEY

CRIMSON QUALITY REPORTING OVERVIEW

PRESENTER: SCOTT KITCHEN

QUESTIONS?

©2011 Proprietary and Confidential

Wrap Up

• We are working on the schedule of User Groups for the 2016CY, please provide feedback on the days/time and frequency of these meetings if you would like something changed

• Continue to email kcortese@chsbuffalo.org with any suggestions for User Group topics

• Copies of the slides will be available on our website:www.catholicmedicalpartners.org